Articles by Ed Hess

1. 4 Questions From The PDA Annual Meeting 4/8/2016

   A few weeks back I attended the 2016 PDA Annual Meeting held in San Antonio. In general, the main thrust of the conference focused on the technologies and approaches being applied by biopharma manufacturers as they move their therapies from development through commercialization.

2. Flexibility Drives Single-Use Bioreactor Choice 3/9/2016

   As biologics manufacturers focus on more niche therapies, single-use bioreactors are projected to see significant worldwide growth.

3. The Challenge Of Getting Cell Therapies To Patients 2/11/2016

   Current cell therapies are both exciting and promising. However, delivering them to a larger pool of patients will prove to be a complicated proposition.

4. 4 Takeaways From Cell & Gene Therapy World 2/1/2016

   Cell and gene therapies hold great promise for patients. Now, the pressure is on the industry to develop processes and solutions that deliver these products economically.